ESR1 and breast carcinoma: Interestingly, tocotrienols too have been able to act as estrogen hormone antagonists, where both estrogen receptor‐negative and positive breast cancer cell lines had shown improved results in suppressing cancer cell proliferation either as single tocotrienol isomers or combinedly as the tocotrienol‐rich fraction (TRF).